Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The New Oral MS Drugs: The Challenges in Dislodging Biologics

Nov 01 2009

Related Content

EU Regulators Up The Number of Tysabri-Related PML Cases, Re-Open a Safety Review

Oct 23 2009

Teva's Copaxone Continues To Widen MS Market Lead In U.S.

Aug 17 2009

Insulin Delivery: Still Waiting to Exhale

Dec 01 2007

MannKind's Uphill Climb to Partner Inhaled Insulin

Sep 01 2009

Novartis Finds FREEDOM From Fingolimod Concerns In Second Phase III, Limits Dose To Play It Safe

Sep 30 2009

Antegren: Shaking Up the MS Market?

Oct 01 2004

Related Companies

Novartis AG

Merck KGaA

Pfizer Inc.

Biogen, Inc.

Elan Corporation

Bayer AG

Bayer AG

Teva Pharmaceutical Industries Ltd.

Sanofi

Active Biotech AB

Teva Pharmaceutical Industries Ltd.

Acorda Therapeutics, Inc.

University of Calgary

Sanofi Genzyme

Rigel Pharmaceuticals, Inc.

ChemoCentryx, Inc.

Vertex Pharmaceuticals Incorporated

Incyte Corporation

MannKind Corporation

Additional Topics

Platform Technologies Regulation BioPharmaceutical

More from In Vivo Archive

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window